{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T18:11:51Z","timestamp":1649009511243},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00508-020-01651-8","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T19:02:30Z","timestamp":1587063750000},"page":"62-64","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms"],"prefix":"10.1007","volume":"133","author":[{"given":"Ivan","family":"Kre\u010dak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nena","family":"Peran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Lapi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Velka","family":"Gveri\u0107-Kre\u010dak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Kre\u010dak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavle","family":"Ron\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadira","family":"Durakovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"1651_CR1","doi-asserted-by":"publisher","first-page":"284706","DOI":"10.1155\/2015\/284706","volume":"2015","author":"HL Geyer","year":"2015","unstructured":"Geyer\u00a0HL, Dueck\u00a0AC, Scherber\u00a0RM, Mesa\u00a0RA. Impact of inflammation on myeloproliferative neoplasm symptom development. Mediators Inflamm. 2015;2015:284706.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"1651_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3324\/haematol.2010.031070","volume":"96","author":"T Barbui","year":"2011","unstructured":"Barbui\u00a0T, Carobbio\u00a0A, Finazzi\u00a0G, et al. Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C\u2011reactive protein and pentraxin 3. Haematologica. 2011;96(2):315\u20138.","journal-title":"Haematologica"},{"issue":"3","key":"1651_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3904\/kjim.2013.28.3.285","volume":"28","author":"H Lee","year":"2013","unstructured":"Lee\u00a0H. Procalcitonin\u00a0as a\u00a0biomarker of infectious diseases. Korean J Intern Med. 2013;28(3):285\u201391.","journal-title":"Korean J Intern Med"},{"issue":"4","key":"1651_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/ard.62.4.337","volume":"62","author":"I Del\u00e8vaux","year":"2003","unstructured":"Del\u00e8vaux\u00a0I, Andr\u00e9\u00a0M, Colombier\u00a0M, et\u00a0al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62(4):337\u201340.","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"1651_CR5","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1002\/cncr.27602","volume":"118","author":"W Shomali","year":"2012","unstructured":"Shomali\u00a0W, Hachem\u00a0R, Chaftari\u00a0AM, et al. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? Cancer. 2012;118(23):5823\u20139.","journal-title":"Cancer"},{"key":"1651_CR6","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber\u00a0DA, Orazi\u00a0A, Hasserjian\u00a0R, et\u00a0al. The 2016 revision to the World Health Organization classification of m\u202fy\u202fe\u202fl\u202fo\u202fi\u202fd neoplasms and acuteleukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood"},{"issue":"17","key":"1651_CR7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics\u00a0R, Passamonti\u00a0F, Buser\u00a0AS, et\u00a0al. A\u00a0gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352(17):1779\u20131790.","journal-title":"N Engl J Med"},{"issue":"2","key":"1651_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00277-002-0584-y","volume":"82","author":"S Sch\u00fcttrumpf","year":"2003","unstructured":"Sch\u00fcttrumpf\u00a0S, Binder\u00a0L, Hagemann\u00a0T, Berkovic\u00a0D, Tr\u00fcmper\u00a0L, Binder\u00a0C. Procalcitonin: a\u00a0useful\u00a0discriminator between febrile conditions of different origin in\u00a0hemato-oncological\u00a0patients? Ann Hematol. 2003;82(2):98\u2013103.","journal-title":"Ann Hematol"},{"issue":"10","key":"1651_CR9","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.leukres.2011.05.035","volume":"5","author":"AC Gac","year":"2011","unstructured":"Gac\u00a0AC, Parienti\u00a0JJ, Chantepie\u00a0S, et\u00a0al. Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia. Leuk Res. 2011;5(10):1294\u20136.","journal-title":"Leuk Res"},{"issue":"3","key":"1651_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4143\/crt.2011.43.3.176","volume":"43","author":"DY Kim","year":"2011","unstructured":"Kim\u00a0DY, Lee\u00a0YS, Ahn\u00a0S, Chun\u00a0YH, Lim\u00a0KS. Procalcitonin\u00a0as a\u00a0useful\u00a0marker\u00a0of\u00a0infection\u00a0in\u00a0hematooncological\u00a0patients\u00a0with\u00a0fever. Cancer Res Treat. 2011;43(3):176\u201380.","journal-title":"Cancer Res Treat"},{"issue":"12","key":"1651_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00277-008-0517-5","volume":"87","author":"F St\u00f6lzel","year":"2008","unstructured":"St\u00f6lzel\u00a0F, Babatz\u00a0J, Thiede\u00a0C, Siegert\u00a0G, Illmer\u00a0T, Ehninger\u00a0G, et al. Cyclic\u00a0severe\u00a0elevated\u00a0procalcitonin\u00a0serum\u00a0levels\u00a0in\u00a0patient\u00a0with\u00a0post\u00a0polycythemic\u00a0myelofibrosis\u00a0carrying\u00a0a\u00a0V617F-JAK2\u00a0mutation. Ann Hematol. 2008;87(12):1021\u20132.","journal-title":"Ann Hematol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-020-01651-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:41:54Z","timestamp":1618533714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-020-01651-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":11,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1007\/s00508-020-01651-8","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"4 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.\u00a0Kre\u010dak, N.\u00a0Peran, I.\u00a0Lapi\u0107, V.\u00a0Gveri\u0107-Kre\u010dak, F.\u00a0Kre\u010dak, P.\u00a0Ron\u010devi\u0107, and N.\u00a0Durakovi\u0107 declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}